Veterans with inflammatory bowel disease taking adalimumab appear to be more likely to remain on the drug 1 year after initiation than patients who are privately insured.
By collecting self-identified social needs and linking them to claims data, this study analysis reveals that social needs are associated with inpatient readmissions.
The authors’ survey of providers in a new accountable care organization reports that initial perceptions of this care model are ambivalent and vary among participating practices.
Being actively treated for cancer increases the mean annual out-of-pocket medical expenditures by $1170 compared with not having cancer.
This article provides an assessment of the downstream impact of coronary artery calcium scanning on the subsequent treatment patterns of non—high-risk patients.
Although clinical trial data have quantified patient survival gains associated with tyrosine kinase inhibitors in chronic myeloid leukemia, the overall value of these benefits is unknown.
Despite uniform access to medical care, Filipinos, blacks, and Asians with diabetes developed albuminuria at higher rates than whites.
The authors aimed to develop a rigorous technique for predicting hospitalizations using data that are already available to most health systems.
The American healthcare system is finally moving away from fee-for-service toward bundled payments, but this transition will only be successful if we shift risk to the physicians.
Nonwhite race, smoking, and increasing body mass index were associated with the lowest adherence trajectories for patients with heart failure, with adherence dropping off within the first year.
Program that enhances personalized and patient-centered preventive care at a busy inner-city primary care clinic may be associated with improved health outcomes.
Improving population health requires developing innovative multistakeholder partnerships to enable mining and cross-leveraging data sets, creating patient touchpoint “ecosystems,” and aligning investments with each stakeholder’s returns.
This literature review evaluates the impact of restricted access to atypical antipsychotic drugs in individuals with schizophrenia or bipolar disorder.